Estadísticas de Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials

Visitas totales

views
Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials 1

Visitas totales por mes

views
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0
August 2025 0
September 2025 0

Visitas de archivo

views
Meza_Angi2021.pdf 43